Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-21
DOI
10.3389/fonc.2021.738626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
- (2021) Kim M. van Pul et al. Frontiers in Immunology
- Humanized Mouse Models to Evaluate Cancer Immunotherapeutics
- (2021) Silvia Guil-Luna et al. Annual Review of Cancer Biology-Series
- Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
- (2021) Nancy Y Lee et al. LANCET ONCOLOGY
- Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
- (2021) Ronan J. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
- (2021) Benjamin Lacas et al. RADIOTHERAPY AND ONCOLOGY
- Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study
- (2021) Danny Rischin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The repertoire of mutational signatures in human cancer
- (2020) Ludmil B. Alexandrov et al. NATURE
- Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
- (2020) Renata Ferrarotto et al. CLINICAL CANCER RESEARCH
- Stereotactic body radiotherapy for medically unfit patients with cancers to the head and neck
- (2020) Hossam Al-Assaf et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
- (2020) Steven F. Powell et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal
- (2020) Shao Hui Huang et al. CANCER
- Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial
- (2020) Ravindra Uppaluri et al. CLINICAL CANCER RESEARCH
- LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
- (2020) J. Bourhis et al. ANNALS OF ONCOLOGY
- Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
- (2020) Sean McBride et al. JOURNAL OF CLINICAL ONCOLOGY
- ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
- (2020) Maria Gebre-Medhin et al. JOURNAL OF CLINICAL ONCOLOGY
- Establishment of patient-derived cancer organoids for drug-screening applications
- (2020) Else Driehuis et al. Nature Protocols
- Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
- (2020) Jonathan D. Schoenfeld et al. JAMA Oncology
- Humanized Rodent Models for Cancer Research
- (2020) Huimin Tian et al. Frontiers in Oncology
- The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer
- (2019) Styliani Melissaridou et al. Cancer Cell International
- Combining conventional therapy with immunotherapy: A risky business?
- (2019) A. Coosemans et al. EUROPEAN JOURNAL OF CANCER
- EAGLE: A phase 3, randomized, open-label study of durvalumab (D) with or without tremelimumab (T) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC).
- (2019) Lisa F. Licitra et al. JOURNAL OF CLINICAL ONCOLOGY
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Oral mucosal organoids as a potential platform for personalized cancer therapy
- (2019) Else Driehuis et al. Cancer Discovery
- Functional Organ Preservation Surgery in Head and Neck Cancer: Transoral Robotic Surgery and Beyond
- (2019) Wojciech Golusiński Frontiers in Oncology
- Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
- (2019) Yuan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
- (2019) Mathieu Grapin et al. Journal for ImmunoTherapy of Cancer
- Radiotherapy with Concurrent and Adjuvant Pembrolizumab in Patients with P16-Positive Locoregionally Advanced Head and Neck Cancer: KEYCHAIN Trial Lead-In Results
- (2019) A.G. Sacco et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer
- (2019) So-Jin Park et al. ORAL ONCOLOGY
- Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer
- (2019) Emile Gogineni et al. Frontiers in Oncology
- Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma
- (2019) Sjoukje F. Oosting et al. Frontiers in Oncology
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
- (2019) Anthony C Nichols et al. LANCET ONCOLOGY
- Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells
- (2019) Jose M. Ayuso et al. Scientific Reports
- An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma
- (2019) Miranda B. Carper et al. Cell Reports
- Immunotherapy for head and neck cancer: Recent advances and future directions
- (2019) John D. Cramer et al. ORAL ONCOLOGY
- Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
- (2019) Zhiyong Wang et al. Nature Communications
- Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy
- (2018) Ariel E. Marciscano et al. CLINICAL CANCER RESEARCH
- Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy
- (2018) Jie Lan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Randomized, Open-Label, Multicenter, Global Phase 2 Study of Durvalumab (D), Tremelimumab (T), or D Plus T, in Patients With PD-L1 Low/Negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: CONDOR
- (2018) L. Siu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
- (2018) Lionnel Geoffrois et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
- (2018) Hisham Mehanna et al. LANCET
- Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
- (2018) Maura L Gillison et al. LANCET
- Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial
- (2017) Kevin J Harrington et al. LANCET ONCOLOGY
- Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
- (2017) Benjamin Lacas et al. LANCET ONCOLOGY
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical models in HNSCC: A comprehensive review
- (2017) Benoite Méry et al. ORAL ONCOLOGY
- Current mouse models of oral squamous cell carcinoma: Genetic and chemically induced models
- (2017) Kazuhisa Ishida et al. ORAL ONCOLOGY
- Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time
- (2017) Shumei Chia et al. Nature Communications
- Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer
- (2016) Diane C. Ling et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational signatures associated with tobacco smoking in human cancer
- (2016) L. B. Alexandrov et al. SCIENCE
- Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
- (2016) J. Liu et al. Cancer Discovery
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Radiotherapy and Immunogenic Cell Death
- (2015) Encouse B. Golden et al. SEMINARS IN RADIATION ONCOLOGY
- Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
- (2014) A. R. de Biasi et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
- (2014) S. V. Hato et al. CLINICAL CANCER RESEARCH
- Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
- (2014) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
- (2014) Joseph M. Curry et al. SEMINARS IN ONCOLOGY
- A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
- (2013) R. Hitt et al. ANNALS OF ONCOLOGY
- Impairing squamous differentiation by Klf4 deletion is sufficient to initiate tongue carcinoma development upon K- Ras activation in mice
- (2013) Marianela Abrigo et al. CARCINOGENESIS
- Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
- (2013) Robert Haddad et al. LANCET ONCOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
- (2012) C.-L. Chang et al. CANCER RESEARCH
- Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma
- (2012) Lai-ping Zhong et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer immunoediting by the innate immune system in the absence of adaptive immunity
- (2012) Timothy O’Sullivan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Comparative Analysis of Tumor-Infiltrating Lymphocytes in a Syngeneic Mouse Model of Oral Cancer
- (2012) Nancy P. Judd et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer
- (2011) Gregory T. Wolf et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Three-Dimensional Cell Growth Confers Radioresistance by Chromatin Density Modification
- (2010) K. Storch et al. CANCER RESEARCH
- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
- (2009) Y. Lee et al. BLOOD
- Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer
- (2009) L. Vitale-Cross et al. Cancer Prevention Research
- Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model
- (2009) A. R. Raimondi et al. CANCER RESEARCH
- Stereotactic Body Radiation Therapy for Primary, Recurrent, and Metastatic Tumors in the Head-and-Neck Region
- (2009) Farzan Siddiqui et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation
- (2009) Sophia Bornstein et al. JOURNAL OF CLINICAL INVESTIGATION
- Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
- (2009) Nancy Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- (2009) Jean-Pierre Pignon et al. RADIOTHERAPY AND ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started